Rodés-Cabau, J, Nombela-Franco, L, Muntané-Carol, G, Veiga, G, Regueiro, A, Nazif, T, Serra, V, Asmarats, L, Ribeiro, HB, Latib, A, Poulin, A, Cheema, AN, Jiménez-Quevedo, P, Gomez-Hospital, JA, Ongay, AG, Gabani, R, Arzamendi, D, Brener, M, Calabuig, A, Scotti, A, Gelain, MAS, Labinaz, M, Cepas-Guillén, P, Nuche, J, Cote, M, Del Portillo, JH, Philippon, F. Prospective validation of a prespecified algorithm for the management of conduction disturbances after transcatheter aortic valve replacement: The PROMOTE study. HEART RHYTHM. 2025; 22(10)DOI:10.1016/j.hrthm.2024.12.019. PMID:39694306. IF:5.700(Q1/2D).

Jamhour-Chelh, K, Jimenez-Kockar, M, Fernandez-Peregrina, E, Arzamendi, D. Dissecting ST-Segment Elevation Myocardial Infarction Pathophysiology Through Invasive Physiology: Prognostic Insight or Actionable Clinical Guidance?. CANADIAN JOURNAL OF CARDIOLOGY. 2025; 41(10)DOI:10.1016/j.cjca.2025.07.015. PMID:40680880. IF:5.300(Q1/2D).

Delgado-Arija, M, Carmena, MDGC, Martínez-Selles, M, Guerra, JM, Valdivielso, S, González-Juanatey, JR, Rivas-Lasarte, M, Roselló-Lleti, E, Perez-Villacastin, J, Carrasquer, A, Matute-Blanco, L, Grande-Trillo, A, Crespo-Leiro, MG, Delgado, JF, Martinez-Dolz, L. Plasma metabolites in patients of the REDINSCOR III registry hospitalised for de novo heart failure with preserved ejection fraction: Prognostic implications of linoleamide and 2-trans,4-cisdecadienoylcarnitine levels. Clinical and Translational Medicine. 2025; 15(9)DOI:10.1002/ctm2.70398. PMID:40947803. IF:6.800(Q1/2D).

Marcos-Mangas, M, López-Sobrino, T, Ariza-Sole, A, Rueda-Sobella, F, Sanz-Girgas, E, Aboal, J, Pastor, P, Buera, I, Sionis, A, Andrea, R, Rodriguez-López, J, Tomas, C, Bañeras, J, Llaó, I, Sánchez-Salado, JC, Garcia-Garcia, C. Socioeconomic status and equity among patients with cardiogenic shock. Frontiers in Cardiovascular Medicine. 2025; 12DOI:10.3389/fcvm.2025.1597225. PMID:40994919. IF:2.900(Q2/4D).